The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neglected Tropical Disease Treatments-Global Market Insights and Sales Trends 2025
Synopsis
The global Neglected Tropical Disease Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neglected Tropical Disease Treatments in various end use industries. The expanding demands from the Clinical Labs, Hospitals /Clinics and Home Healthcare,, are propelling Neglected Tropical Disease Treatments market. Conventional Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular/Modern Method segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neglected Tropical Disease Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neglected Tropical Disease Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neglected Tropical Disease Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neglected Tropical Disease Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neglected Tropical Disease Treatments covered in this report include F. Hoffmann-La Roche Ltd., Abbott, ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Ltd, Omega Diagnostics Group PLC, Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH and Oscar Medicare Pvt Ltd., etc.
The global Neglected Tropical Disease Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche Ltd.
Abbott
ZeptoMetrix
InBios International, Inc.
Genome Diagnostics Pvt. Ltd
Omega Diagnostics Group PLC
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
Oscar Medicare Pvt Ltd.
Thermo Fisher Scientific, Inc.
Global Neglected Tropical Disease Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neglected Tropical Disease Treatments market, Segment by Type:
Conventional Method
Molecular/Modern Method
Global Neglected Tropical Disease Treatments market, by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neglected Tropical Disease Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Neglected Tropical Disease Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neglected Tropical Disease Treatments in various end use industries. The expanding demands from the Clinical Labs, Hospitals /Clinics and Home Healthcare,, are propelling Neglected Tropical Disease Treatments market. Conventional Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular/Modern Method segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neglected Tropical Disease Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neglected Tropical Disease Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neglected Tropical Disease Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neglected Tropical Disease Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neglected Tropical Disease Treatments covered in this report include F. Hoffmann-La Roche Ltd., Abbott, ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Ltd, Omega Diagnostics Group PLC, Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH and Oscar Medicare Pvt Ltd., etc.
The global Neglected Tropical Disease Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche Ltd.
Abbott
ZeptoMetrix
InBios International, Inc.
Genome Diagnostics Pvt. Ltd
Omega Diagnostics Group PLC
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
Oscar Medicare Pvt Ltd.
Thermo Fisher Scientific, Inc.
Global Neglected Tropical Disease Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neglected Tropical Disease Treatments market, Segment by Type:
Conventional Method
Molecular/Modern Method
Global Neglected Tropical Disease Treatments market, by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neglected Tropical Disease Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neglected Tropical Disease Treatments
1.1 Neglected Tropical Disease Treatments Market Overview
1.1.1 Neglected Tropical Disease Treatments Product Scope
1.1.2 Neglected Tropical Disease Treatments Market Status and Outlook
1.2 Global Neglected Tropical Disease Treatments Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neglected Tropical Disease Treatments Market Size by Region (2018-2029)
1.4 Global Neglected Tropical Disease Treatments Historic Market Size by Region (2018-2023)
1.5 Global Neglected Tropical Disease Treatments Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neglected Tropical Disease Treatments Market Size (2018-2029)
1.6.1 North America Neglected Tropical Disease Treatments Market Size (2018-2029)
1.6.2 Europe Neglected Tropical Disease Treatments Market Size (2018-2029)
1.6.3 Asia-Pacific Neglected Tropical Disease Treatments Market Size (2018-2029)
1.6.4 Latin America Neglected Tropical Disease Treatments Market Size (2018-2029)
1.6.5 Middle East & Africa Neglected Tropical Disease Treatments Market Size (2018-2029)
2 Neglected Tropical Disease Treatments Market by Type
2.1 Introduction
2.1.1 Conventional Method
2.1.2 Molecular/Modern Method
2.2 Global Neglected Tropical Disease Treatments Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neglected Tropical Disease Treatments Historic Market Size by Type (2018-2023)
2.2.2 Global Neglected Tropical Disease Treatments Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neglected Tropical Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neglected Tropical Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neglected Tropical Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neglected Tropical Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neglected Tropical Disease Treatments Revenue Breakdown by Type (2018-2029)
3 Neglected Tropical Disease Treatments Market Overview by Application
3.1 Introduction
3.1.1 Clinical Labs
3.1.2 Hospitals /Clinics
3.1.3 Home Healthcare
3.2 Global Neglected Tropical Disease Treatments Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neglected Tropical Disease Treatments Historic Market Size by Application (2018-2023)
3.2.2 Global Neglected Tropical Disease Treatments Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neglected Tropical Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neglected Tropical Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neglected Tropical Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neglected Tropical Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neglected Tropical Disease Treatments Revenue Breakdown by Application (2018-2029)
4 Neglected Tropical Disease Treatments Competition Analysis by Players
4.1 Global Neglected Tropical Disease Treatments Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neglected Tropical Disease Treatments as of 2022)
4.3 Date of Key Players Enter into Neglected Tropical Disease Treatments Market
4.4 Global Top Players Neglected Tropical Disease Treatments Headquarters and Area Served
4.5 Key Players Neglected Tropical Disease Treatments Product Solution and Service
4.6 Competitive Status
4.6.1 Neglected Tropical Disease Treatments Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche Ltd.
5.1.1 F. Hoffmann-La Roche Ltd. Profile
5.1.2 F. Hoffmann-La Roche Ltd. Main Business
5.1.3 F. Hoffmann-La Roche Ltd. Neglected Tropical Disease Treatments Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Ltd. Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Neglected Tropical Disease Treatments Products, Services and Solutions
5.2.4 Abbott Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 ZeptoMetrix
5.3.1 ZeptoMetrix Profile
5.3.2 ZeptoMetrix Main Business
5.3.3 ZeptoMetrix Neglected Tropical Disease Treatments Products, Services and Solutions
5.3.4 ZeptoMetrix Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.3.5 InBios International, Inc. Recent Developments
5.4 InBios International, Inc.
5.4.1 InBios International, Inc. Profile
5.4.2 InBios International, Inc. Main Business
5.4.3 InBios International, Inc. Neglected Tropical Disease Treatments Products, Services and Solutions
5.4.4 InBios International, Inc. Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.4.5 InBios International, Inc. Recent Developments
5.5 Genome Diagnostics Pvt. Ltd
5.5.1 Genome Diagnostics Pvt. Ltd Profile
5.5.2 Genome Diagnostics Pvt. Ltd Main Business
5.5.3 Genome Diagnostics Pvt. Ltd Neglected Tropical Disease Treatments Products, Services and Solutions
5.5.4 Genome Diagnostics Pvt. Ltd Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.5.5 Genome Diagnostics Pvt. Ltd Recent Developments
5.6 Omega Diagnostics Group PLC
5.6.1 Omega Diagnostics Group PLC Profile
5.6.2 Omega Diagnostics Group PLC Main Business
5.6.3 Omega Diagnostics Group PLC Neglected Tropical Disease Treatments Products, Services and Solutions
5.6.4 Omega Diagnostics Group PLC Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.6.5 Omega Diagnostics Group PLC Recent Developments
5.7 Coris Bioconcept SPRL
5.7.1 Coris Bioconcept SPRL Profile
5.7.2 Coris Bioconcept SPRL Main Business
5.7.3 Coris Bioconcept SPRL Neglected Tropical Disease Treatments Products, Services and Solutions
5.7.4 Coris Bioconcept SPRL Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.7.5 Coris Bioconcept SPRL Recent Developments
5.8 DiaSys Diagnostic Systems GmbH
5.8.1 DiaSys Diagnostic Systems GmbH Profile
5.8.2 DiaSys Diagnostic Systems GmbH Main Business
5.8.3 DiaSys Diagnostic Systems GmbH Neglected Tropical Disease Treatments Products, Services and Solutions
5.8.4 DiaSys Diagnostic Systems GmbH Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.8.5 DiaSys Diagnostic Systems GmbH Recent Developments
5.9 Oscar Medicare Pvt Ltd.
5.9.1 Oscar Medicare Pvt Ltd. Profile
5.9.2 Oscar Medicare Pvt Ltd. Main Business
5.9.3 Oscar Medicare Pvt Ltd. Neglected Tropical Disease Treatments Products, Services and Solutions
5.9.4 Oscar Medicare Pvt Ltd. Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.9.5 Oscar Medicare Pvt Ltd. Recent Developments
5.10 Thermo Fisher Scientific, Inc.
5.10.1 Thermo Fisher Scientific, Inc. Profile
5.10.2 Thermo Fisher Scientific, Inc. Main Business
5.10.3 Thermo Fisher Scientific, Inc. Neglected Tropical Disease Treatments Products, Services and Solutions
5.10.4 Thermo Fisher Scientific, Inc. Neglected Tropical Disease Treatments Revenue (US$ Million) & (2018-2023)
5.10.5 Thermo Fisher Scientific, Inc. Recent Developments
6 North America
6.1 North America Neglected Tropical Disease Treatments Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neglected Tropical Disease Treatments Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Disease Treatments Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neglected Tropical Disease Treatments Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Disease Treatments Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neglected Tropical Disease Treatments Market Dynamics
11.1 Neglected Tropical Disease Treatments Industry Trends
11.2 Neglected Tropical Disease Treatments Market Drivers
11.3 Neglected Tropical Disease Treatments Market Challenges
11.4 Neglected Tropical Disease Treatments Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
